MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27

被引:0
|
作者
Yong Yang
Yan Bao
Guo-Kai Yang
Jia Wan
Ling-Juan Du
Zhen-Huan Ma
机构
[1] The Second People’s Hospital of Yunnan Province,The Third Department of General Surgery
[2] The Fourth Affiliated Hospital of Kunming MedicalUniversity,Department of Vascular Surgery
来源
关键词
miR-214; Hsp27; 3′-UTR; 5-FU; Colon cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Overcoming chemorestistance to 5-fluorouracil (5-FU) could offer a new treatment option for highly malignant colon cancer. In our study, differential microRNA expression profiling revealed that miR-214 is downregulated in 5-FU-resistant colon cancer cells compared to normal cells. In vitro, miR-214 could sensitize non-resistant colon cancer cells and 5-FU-resistant colon cancer cellsto 5-FU. Functionally, miR-214 inhibited cell clone formation and cell growth and enhanced 5-FU-inducing cell apoptosis and caspase-3 levels. MiR-214 targeted heat shock protein 27 (Hsp27), as confirmed via dual luciferase reporter assays and western blots. Hsp27 also sensitized HT-29 and LoVo to 5-FU by enhancing cell apoptosis. Overexpression of Hsp27 could block miR-214 with an effect on the sensitivity of colon cancer cells to 5-FU. In conclusion, miR-214 sensitizes colon cancer cells to 5-FU by targeting Hsp27, indicating a significant role for this miRNA in colon cancer chemotherapy.
引用
收藏
相关论文
共 50 条
  • [21] α-Hederin Potentiates 5-FU Antitumor Activity in Human Colon Adenocarcinoma Cells
    Bun, Sok-Siya
    Elias, Riad
    Baghdikian, Beatrice
    Ciccolini, Joseph
    Ollivier, Evelyne
    Balansard, Guy
    PHYTOTHERAPY RESEARCH, 2008, 22 (10) : 1299 - 1302
  • [22] Rutin enhances the antiproliferative effect of 5-FU and oxaliplatin in colon cancer cells
    Nasiri, Farnoud
    Kismali, Gorkem
    Alpay, Merve
    Kosova, Funda
    Cakir, Dilek Ulker
    Sel, Tevhide
    CANCER RESEARCH, 2016, 76
  • [23] ANXA1 is involved in resistance to 5-FU in colon cancer cells
    Saito, Motonobu
    Onozawa, Hisashi
    Sakuyama, Misato
    Ashizawa, Mai
    Kikuchi, Tomohiro
    Okayama, Hirokazu
    Endo, Hisahito
    Fujita, Shotaro
    Sakamoto, Wataru
    Saze, Zenichiro
    Momma, Tomoyuki
    Ohki, Shinji
    Kono, Koji
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [24] Down-regulation of Hsp27 radiosensitizes human prostate cancer cells
    Teimourian, Shahram
    Jalal, Razieh
    Sohrabpour, Mostafa
    Goliaei, Bahram
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (09) : 1221 - 1225
  • [25] Annexin A1 is involved in resistance to 5-FU in colon cancer cells
    Onozawa, Hisashi
    Saito, Motonobu
    Saito, Katsuharu
    Kanke, Yasuyuki
    Watanabe, Yohei
    Hayase, Suguru
    Sakamoto, Wataru
    Ishigame, Teruhide
    Momma, Tomoyuki
    Ohki, Shinji
    Takenoshita, Seiichi
    ONCOLOGY REPORTS, 2017, 37 (01) : 235 - 240
  • [26] Zhenbao Pill reduces Treg cell proportion in acute spinal cord injury rats by regulating TUG1/miR-214/HSP27 axis
    He, Yongxiong
    Li, Mingdong
    Wujisiguleng
    Lv, Bokang
    Huan, Yanqiang
    Liu, Bin
    Wang, Dongsheng
    Yu, Hai
    Zhang, Liansheng
    Shi, Zhiqiang
    BIOSCIENCE REPORTS, 2018, 38
  • [27] LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan
    Fakhr, Elham
    Zare, Fatemeh
    Azadmanesh, Kayhan
    Teimoori-Toolabi, Ladan
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 143
  • [28] Inhibition of cystathionine-β-synthase (CBS) sensitizes colon cancer cells to 5-FU via increasing apoptosis and inhibiting cellular bioenergetics
    Chen, Shanwen
    Wang, Pengyuan
    Pan, Yisheng
    Liu, Yucun
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers
    Yoo, Hawon
    Choi, Seul-Ki
    Lee, Jaeok
    Park, So Hyeon
    Park, You Na
    Hwang, Soo-Yeon
    Shin, Jae-Ho
    Na, Younghwa
    Kwon, Youngjoo
    Lee, Hwa Jeong
    Lee, Yun-Sil
    PHARMACEUTICS, 2021, 13 (05)
  • [30] Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy
    Diaz-Chavez, Jose
    Fonseca-Sanchez, Miguel A.
    Arechaga-Ocampo, Elena
    Flores-Perez, Ali
    Palacios-Rodriguez, Yadira
    Dominguez-Gomez, Guadalupe
    Marchat, Laurence A.
    Fuentes-Mera, Lizeth
    Mendoza-Hernandez, Guillermo
    Gariglio, Patricio
    Lopez-Camarillo, Cesar
    PLOS ONE, 2013, 8 (05):